Adam RA, Adam YG (2004) Malignant ascites: past, present, and future. J Am Coll Surg 198:999–1011. https://doi.org/10.1016/j.jamcollsurg.2004.01.035

Article  PubMed  Google Scholar 

Adhikary T, Wortmann A, Finkernagel F, Lieber S, Nist A, Stiewe T, Wagner U, Muller-Brusselbach S, Reinartz S, Muller R (2017) Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients. BMC Genom 18:243. https://doi.org/10.1186/s12864-017-3630-9

CAS  Article  Google Scholar 

Ahmed N, Escalona R, Leung D, Chan E, Kannourakis G (2018) Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells. Semin Cancer Biol 53:265–281. https://doi.org/10.1016/j.semcancer.2018.10.002

CAS  Article  PubMed  Google Scholar 

Arend RC, Scalise CB, Gordon ER, Davis AM, Foxall ME, Johnston BE, Crossman DK, Cooper SJ (2022) Metabolic alterations and WNT signaling impact immune response in HGSOC. Clin Cancer Res 28:1433–1445. https://doi.org/10.1158/1078-0432.CCR-21-2984

CAS  Article  PubMed  PubMed Central  Google Scholar 

Baert T, Vankerckhoven A, Riva M, Van Hoylandt A, Thirion G, Holger G, Mathivet T, Vergote I, Coosemans A (2019) Myeloid derived suppressor cells: key drivers of immunosuppression in ovarian cancer. Front Immunol 10:1273. https://doi.org/10.3389/fimmu.2019.01273

CAS  Article  PubMed  PubMed Central  Google Scholar 

Bamias A, Koutsoukou V, Terpos E, Tsiatas ML, Liakos C, Tsitsilonis O, Rodolakis A, Voulgaris Z, Vlahos G, Papageorgiou T et al (2008) Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy. Gynecol Oncol 108:421–427. https://doi.org/10.1016/j.ygyno.2007.10.018

CAS  Article  PubMed  Google Scholar 

Bekes I, Friedl TW, Kohler T, Mobus V, Janni W, Wockel A, Wulff C (2016) Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer? Mol Cancer 15:13. https://doi.org/10.1186/s12943-016-0497-3

CAS  Article  PubMed  PubMed Central  Google Scholar 

Bhattacharya P, Sett S, Maity P (2001) Effect of purified glutaminase from human ascites fluid on experimental tumor bearing mice. J Exp Clin Cancer Res 20:599–607.

CAS  PubMed  Google Scholar 

Bortot B, Apollonio M, Rampazzo E, Valle F, Brucale M, Ridolfi A, Ura B, Addobbati R, Di Lorenzo G, Romano F et al (2021) Small extracellular vesicles from malignant ascites of patients with advanced ovarian cancer provide insights into the dynamics of the extracellular matrix. Mol Oncol 15:3596-3614. https://doi.org/10.1002/1878-0261.13110

Brechbuhl HM, Finlay-Schultz J, Yamamoto TM, Gillen AE, Cittelly DM, Tan AC, Sams SB, Pillai MM, Elias AD, Robinson WA et al (2017) Fibroblast subtypes regulate responsiveness of luminal breast cancer to estrogen. Clin Cancer Res 23:1710–1721. https://doi.org/10.1158/1078-0432.CCR-15-2851

CAS  Article  PubMed  Google Scholar 

Brencicova E, Jagger AL, Evans HG, Georgouli M, Laios A, Attard Montalto S, Mehra G, Spencer J, Ahmed AA, Raju-Kankipati S et al (2017) Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma. PLoS ONE 12:e0175712. https://doi.org/10.1371/journal.pone.0175712

CAS  Article  PubMed  PubMed Central  Google Scholar 

Brown S, Pineda CM, Xin T, Boucher J, Suozzi KC, Park S, Matte-Martone C, Gonzalez DG, Rytlewski J, Beronja S et al (2017) Correction of aberrant growth preserves tissue homeostasis. Nature 548:334–337. https://doi.org/10.1038/nature23304

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cao L, Shao M, Schilder J, Guise T, Mohammad KS, Matei D (2012) Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene 31:2521–2534. https://doi.org/10.1038/onc.2011.429

CAS  Article  PubMed  Google Scholar 

Castro F, Cardoso AP, Goncalves RM, Serre K, Oliveira MJ (2018) Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Front Immunol 9:847. https://doi.org/10.3389/fimmu.2018.00847

CAS  Article  PubMed  PubMed Central  Google Scholar 

Chen RR, Yung MMH, Xuan Y, Zhan S, Leung LL, Liang RR, Leung THY, Yang H, Xu D, Sharma R et al (2019) Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells. Commun Biol 2:281. https://doi.org/10.1038/s42003-019-0508-1

CAS  Article  PubMed  PubMed Central  Google Scholar 

Chen P, Hsu WH, Chang A, Tan Z, Lan Z, Zhou A, Spring DJ, Lang FF, Wang YA, DePinho RA (2020) Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment. Cancer Discov 10:371–381. https://doi.org/10.1158/2159-8290.CD-19-0400

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cohen M, Petignat P (2014) The bright side of ascites in ovarian cancer. Cell Cycle 13:2319. https://doi.org/10.4161/cc.29951

CAS  Article  PubMed  PubMed Central  Google Scholar 

Condamine T, Ramachandran I, Youn JI, Gabrilovich DI (2015) Regulation of tumor metastasis by myeloid-derived suppressor cells. Annu Rev Med 66:97–110. https://doi.org/10.1146/annurev-med-051013-052304

CAS  Article  PubMed  Google Scholar 

Correa RJ, Valdes YR, Shepherd TG, DiMattia GE (2015) Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro. J Ovarian Res 8:52. https://doi.org/10.1186/s13048-015-0182-y

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cuneo MG, Szeto A, Schrepf A, Kinner EM, Schachner BI, Ahmed R, Thaker PH, Goodheart M, Bender D, Cole SW et al (2019) Oxytocin in the tumor microenvironment is associated with lower inflammation and longer survival in advanced epithelial ovarian cancer patients. Psychoneuroendocrinology 106:244–251. https://doi.org/10.1016/j.psyneuen.2019.04.007

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cuneo MG, Szeto A, Schrepf A, Thaker PH, Goodheart M, Cole SW, Sood AK, McCabe PM, Mendez AJ, Lutgendorf SK (2021) Positive psychosocial factors and oxytocin in the ovarian tumor microenvironment. Psychosom Med 83:417–422. https://doi.org/10.1097/PSY.0000000000000935

CAS  Article  PubMed  PubMed Central  Google Scholar 

Curiel TJ, Cheng P, Mottram P, Alvarez X, Moons L, Evdemon-Hogan M, Wei S, Zou L, Kryczek I, Hoyle G et al (2004a) Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res 64:5535–5538. https://doi.org/10.1158/0008-5472.CAN-04-1272

CAS  Article  PubMed  Google Scholar 

Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M et al (2004b) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949. https://doi.org/10.1038/nm1093

CAS  Article  PubMed  Google Scholar 

Czystowska-Kuzmicz M, Sosnowska A, Nowis D, Ramji K, Szajnik M, Chlebowska-Tuz J, Wolinska E, Gaj P, Grazul M, Pilch Z et al (2019) Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat Commun 10:3000. https://doi.org/10.1038/s41467-019-10979-3

CAS  Article  PubMed  PubMed Central  Google Scholar 

da Silva RF, Yoshida A, Cardozo DM, Jales RM, Paust S, Derchain S, Guimaraes F (2017) Natural killer cells response to IL-2 stimulation is distinct between ascites with the presence or absence of malignant cells in ovarian cancer patients. Int J Mol Sci 18:856. https://doi.org/10.3390/ijms18050856

Dalal V, Kumar R, Kumar S, Sharma A, Kumar L, Sharma JB, Roy KK, Singh N, Vanamail P (2018) Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients. Clin Chim Acta 482:27–32. https://doi.org/10.1016/j.cca.2018.03.019

CAS  Article  PubMed  Google Scholar 

de Bruyn M, Wiersma VR, Wouters MC, Samplonius DF, Klip HG, Helfrich W, Nijman HW, Eggleton P, Bremer E (2015) CD20(+) T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer. Oncoimmunology 4:e999536. https://doi.org/10.1080/2162402X.2014.999536

CAS  Article  PubMed  PubMed Central  Google Scholar 

Di Modica M, Gargari G, Regondi V, Bonizzi A, Arioli S, Belmonte B, De Cecco L, Fasano E, Bianchi F, Bertolotti A et al (2021) Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer. Cancer Res 81:2195–2206. https://doi.org/10.1158/0008-5472.CAN-20-1659

Article  PubMed  Google Scholar 

Dijkgraaf EM, Heusinkveld M, Tummers B, Vogelpoel LT, Goedemans R, Jha V, Nortier JW, Welters MJ, Kroep JR, van der Burg SH (2013) Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer Res 73:2480–2492. https://doi.org/10.1158/0008-5472.CAN-12-3542

CAS  Article  PubMed  Google Scholar 

Ding Y, Labitzky V, Legler K, Qi M, Schumacher U, Schmalfeldt B, Sturken C, Oliveira-Ferrer L (2021) Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer. Mol Oncol 15:3578–3595. https://doi.org/10.1002/1878-0261.13028

CAS  Article  PubMed  PubMed Central  Google Scholar 

Dolinschek R, Hingerl J, Benge A, Zafiu C, Schuren E, Ehmoser EK, Lossner D, Reuning U (2021) Constitutive activation of integrin alphavbeta3 contributes to anoikis resistance of ovarian cancer cells. Mol Oncol 15:503–522. https://doi.org/10.1002/1878-0261.12845

CAS  Article  PubMed  Google Scholar 

Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, Lenoir J, Preisser L, Anegon I, Catala L, Ifrah N et al (2007) Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 110:4319–4330. https://doi.org/10.1182/blood-2007-02-072587

CAS  Article  PubMed  Google Scholar 

Duluc D, Corvaisier M, Blanchard S, Catala L, Descamps P, Gamelin E, Ponsoda S, Delneste Y, Hebbar M, Jeannin P (2009) Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int J Cancer 125:367–373. https://doi.org/10.1002/ijc.24401

CAS  Article  PubM